Fixed Price IPO | ₹19 Cr | Listed at NSE SME | Mon, Sep 29, 2025 - Wed, Oct 1, 2025
Vijaypd Ceutical IPO is a fixed price issue of ₹19.25 crores. The issue is entirely a fresh issue of 0.55 crore shares of ₹19.25 crore.
Vijaypd Ceutical IPO bidding started from Sep 29, 2025 and ended on Oct 1, 2025. The allotment for Vijaypd Ceutical IPO was finalized on Oct 3, 2025. The shares got listed on NSE SME on Oct 7, 2025.
Vijaypd Ceutical IPO price is ₹35 per share. The lot size for an application is 4,000. The minimum amount of investment required by an individual investor (retail) is ₹2,80,000 (8,000 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (12,000 shares), amounting to ₹4,20,000.
Smart Horizon Capital Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Shreni Shares Ltd..
Refer to Vijaypd Ceutical IPO DRHP for detailed Information.
IPO Open
Mon, Sep 29, 2025
IPO Close
Wed, Oct 1, 2025
Issue Price
₹35 per share
Market Cap (Pre-IPO)
To be declared
| IPO Date | 29 Sep to 1 Oct, 2025 |
| Listed on | Tue, Oct 7, 2025 |
| Face Value | ₹10 per share |
| Issue Price | ₹35 per share |
| Lot Size | 4,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Total Issue Size | 55,00,000 shares (agg. up to ₹19 Cr) |
| Reserved for Market Maker | 2,84,000 shares Shreni Shares Ltd. (agg. up to ₹0.9940 Cr) |
| Fresh Issue (Ex Market Maker) | 52,16,000 shares (agg. up to ₹18 Cr) |
| Net Offered to Public | 52,16,000 shares (agg. up to ₹18 Cr) |
| Share Holding Pre Issue | 1,40,28,686 shares |
| Share Holding Post Issue | 1,95,28,686 shares |
| NSE Symbol | VIJAYPD |
| ISIN | INE0WL901019 |
Vijaypd Ceutical IPO comprises a total issue size of 55,00,000 shares. The net offer to the public is 52,16,000 shares, after excluding 2,84,000 shares allotted on a firm basis. Of the Net offer 26,08,000 (50.00%) allocated to NII 26,08,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 26,08,000 | 50.00% | 47.42% |
| Retail Shares Offered | 26,08,000 | 50.00% | 47.42% |
| Firm Reservations | |||
| Market Maker Shares Offered | 2,84,000 | 5.16% | |
| Total Shares Offered | 55,00,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 8,000 shares and in multiples of 4,000 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 8,000 | ₹2,80,000 |
| Individual investors (Retail) (Max) | 2 | 8,000 | ₹2,80,000 |
| HNI (Min) | 3 | 12,000 | ₹4,20,000 |
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.
The company acts as representatives, dealers, agents, stockists, suppliers, traders, and packers.
The company serves the pharmaceutical and wellness industries, as well as the FMCG market, offering products like medicines (injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, liquid oral products), vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, personal care items (soaps, sanitizers, baby care), ayurvedic products, cosmetics, food products, dental products, and crude drugs.
As of Marc 31, 2025, the company serves over r 2,109 pharmacies, clinics, and nursing homes across four districts, covering 20 locations.
The company's distribution network connects with over 170 healthcare product manufacturers, providing access to more than 19,000 SKUs.
This product portfolio allows the company to meet customer needs while ensuring quality and reliability in pharmaceutical supply.
The company is a pharmaceutical distributor with FDA, FSSAI, and BMC certifications.
Competitive Strength:
Vijaypd Ceutical Ltd.'s revenue increased by 98% and profit after tax (PAT) rose by 191% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 57.15 | 33.27 | 32.87 |
| Total Income | 107.59 | 54.34 | 50.59 |
| Profit After Tax | 4.80 | 1.65 | 0.18 |
| EBITDA | 8.59 | 4.87 | 1.32 |
| NET Worth | 32.17 | 1.00 | 4.93 |
| Reserves and Surplus | 18.14 | ||
| Total Borrowing | 21.77 | 30.04 | 25.56 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding of capital expenditure requirements of the company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC – Shrirampur, Ahmednagar, Maharashtra | 10.83 |
| 2 | Repayment/prepayment of all or certain of the borrowings availed of by the Company | 5.10 |
| 3 | General corporate purposes | 0.74 |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 28.91% |
| ROCE | 17.30% |
| Debt/Equity | 0.68 |
| RoNW | 14.91% |
| PAT Margin | 4.49% |
| EBITDA Margin | 8.04% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 78.3% | 56.25% |
The Vijaypd Ceutical IPO is subscribed 1.37 times on October 1, 2025 6:19:10 PM (Day 3). The public issue subscribed 0.89 times in the individual investors category, [.] times in the QIB category, and 1.86 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for | Total Application |
|---|---|---|---|---|
| NII* | 1.86 | 26,08,000 | 48,44,000 | 0 |
| Individual Investor | 0.89 | 26,08,000 | 23,20,000 | 290 |
| Total | 1.37 | 52,16,000 | 71,64,000 | 401 |
Total Application : 401
*Market Maker portion is not included to NII/HNI.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Brokerage, selling, commission and upload fees | 0.01 |
| 2 | Registrar to the issue | 0.02 |
| 3 | Legal Advisors | 0.02 |
| 4 | Advertising and Marketing expenses | 0.03 |
| 5 | Regulators including stock exchanges | 0.04 |
| 6 | Printing and distribution of issue stationery | 0.01 |
| 7 | Others, if any (market making, depositories, industry report fees, marketing fees, secretarial, peer review etc.) | 0.28 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹35.00 |
| Open | ₹35.00 |
| Low | ₹35.00 |
| High | ₹36.75 |
| Last Trade | ₹35.90 |
Lead Manager Reports
Vijaypd Ceutical IPO is a SME IPO of 55,00,000 equity shares of the face value of ₹10 aggregating up to ₹19 Crores. The issue is priced at ₹35 per share. The minimum order quantity is 4000.
The IPO opens on Mon, Sep 29, 2025, and closes on Wed, Oct 1, 2025.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Vijaypd Ceutical IPO using UPI as a payment gateway. Zerodha customers can apply in Vijaypd Ceutical IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Vijaypd Ceutical IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Vijaypd Ceutical IPO opens on Mon, Sep 29, 2025 and closes on Wed, Oct 1, 2025.
Vijaypd Ceutical IPO lot size is 4000, and the minimum amount required for application is ₹2,80,000, with 2 lots being the minimum application size.
You can apply in Vijaypd Ceutical IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Vijaypd Ceutical IPO will be done on Friday, October 3, 2025, and the allotted shares will be credited to your demat account by Mon, Oct 6, 2025. Check the Vijaypd Ceutical IPO allotment status.
The Vijaypd Ceutical IPO listing date is on Tue, Oct 7, 2025.
